» Authors » Cengiz Demir

Cengiz Demir

Explore the profile of Cengiz Demir including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 135
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aslan S, Demir C, Kurtoglu E, Altindis M
Cureus . 2024 Sep; 16(8):e65996. PMID: 39221349
Background Antibiotic resistance is a significant public health issue worldwide. Antibiotic-resistant zoonotic bacteria such as (), , , , , and can be particularly isolated from biofertilizers. Epidemiological studies have...
2.
Gurbuz M, Turkekul Sen E, Simsek M, Demir C
Cureus . 2024 Jul; 16(6):e61538. PMID: 38957246
Background The escalating global rise in multidrug-resistant gram-negative bacteria presents an increasingly substantial threat to patient safety. Over the past decade, carbapenem-resistant Enterobacterales (CRE) have emerged as one of the...
3.
Beyler O, Demir C
Exp Clin Transplant . 2023 Dec; 21(11):921-924. PMID: 38140936
Corticosteroids have a wide range of uses. The most commonadverse side effectsofhigh-dosepulse steroids are hyperglycemia, gastrointestinal intolerance, and psychiatric symptoms. Cardiac arrhythmias have been reported in patients who receive high-dose...
4.
Beyler O, Demir C
Transfus Apher Sci . 2023 May; 62(4):103713. PMID: 37137784
There is limited data on the use of NAC in the literature. We would like to present the satisfactory results we obtained in our resistant and relapsed patients as a...
5.
Ozatli D, Giden A, Erkurt M, Korkmaz S, Basci S, Ulas T, et al.
Transfus Apher Sci . 2023 Feb; 62(2):103662. PMID: 36842884
Therapeutic apheresis is an extracorporeal treatment that selectively removes abnormal cells or harmful substances in the blood that are associated with or cause certain diseases. During the last decades the...
6.
Demircioglu S, Dogan A, Demir C
J Coll Physicians Surg Pak . 2021 Oct; 31(11):1359-1361. PMID: 34689499
Thrombotic microangiopathy (TMA) associated with hematopoietic stem cell transplantation, remains a difficult complication due to its high mortality rate, lack of standardised diagnostic criteria, and limited treatment options. Although the...
7.
Goren Sahin D, Akay O, Keklik M, Okan V, Karakus A, Demir C, et al.
Ann Hematol . 2021 May; 100(7):1667-1675. PMID: 33988739
The aim of this study is to collect paroxysmal nocturnal hemoglobinuria (PNH) patient data from hematology centers all over Turkey in order to identify clinical features and management of PNH...
8.
Gunay E, Ozan M, Kaya S, Ocal E, Kutlu Z, Senol A, et al.
Ren Fail . 2021 Mar; 43(1):460-462. PMID: 33657972
No abstract available.
9.
Demir C, Ebinc S, Ekinci O
Turk J Med Sci . 2020 Jun; 50(5):1344-1349. PMID: 32490645
Background/aim: Paroxysmal nocturnal hemoglobinuria (PNH) is a very rare clonal hematopoietic stem cell disease characterized by chronic hemolytic anemia and thrombosis. We report data from a study of the occurrence...
10.
Duzen Oflas N, Demircioglu S, Yildirim Dogan N, Eker E, Kutlucan A, Dogan A, et al.
Intern Med J . 2020 Jan; 50(7):854-858. PMID: 31994303
Background: It is known that daily divided doses and high doses of iron increase hepcidin and reduce iron absorption. Aim: This study aimed to compare treatments of iron replacement every...